145 related articles for article (PubMed ID: 14740604)
1. Global fund decides to promote use of generic drugs.
Elliott R
Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):58-9. PubMed ID: 14740604
[No Abstract] [Full Text] [Related]
2. Working together to provide generics for health.
Beck EJ; Reiss P
Antivir Ther; 2014; 19 Suppl 3():1. PubMed ID: 25310234
[No Abstract] [Full Text] [Related]
3. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
4. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
Tucker T; Yeats J
S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
[No Abstract] [Full Text] [Related]
5. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
6. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
7. Canada's plan to sell generic drugs to developing countries is threatened.
Spurgeon D
BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278
[No Abstract] [Full Text] [Related]
8. Kenya says yes to generic ARVs but fails to win Global Fund cash.
Njoroge J
Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
[No Abstract] [Full Text] [Related]
9. Generic drugs battle moves from South Africa to Kenya.
Siringi S
Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
[No Abstract] [Full Text] [Related]
10. Policy shift. Bush's AIDS plan includes condom distribution, generic drugs.
AIDS Policy Law; 2003 Feb; 18(3):5. PubMed ID: 12635615
[No Abstract] [Full Text] [Related]
11. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
12. The future of generic HIV drugs in Rhode Island.
Lee JY; Reece R; Montague B; Rana A; Alexander-Scott N; Flanigan T
R I Med J (2013); 2013 Sep; 96(9):30-3. PubMed ID: 24015398
[TBL] [Abstract][Full Text] [Related]
13. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
14. Is there a role for generic antiretroviral drugs in the United States?
Wormser GP; Lappas T
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
[TBL] [Abstract][Full Text] [Related]
15. Bush accused of blocking access to cheap AIDS drugs.
Dyer O
BMJ; 2004 Apr; 328(7443):783. PubMed ID: 15070614
[No Abstract] [Full Text] [Related]
16. Cheap HIV drugs for developing countries.
Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820
[No Abstract] [Full Text] [Related]
17. Poor countries should use flexibility in global trade agreement to improve access to antiretrovirals, says report.
Zarocostas J
BMJ; 2011 Mar; 342():d1677. PubMed ID: 21411492
[No Abstract] [Full Text] [Related]
18. The discovery and development of antiretroviral agents.
Lange JM; Ananworanich J
Antivir Ther; 2014; 19 Suppl 3():5-14. PubMed ID: 25310317
[TBL] [Abstract][Full Text] [Related]
19. Access to essential medications for HIV/AIDS in South Africa.
Andrews S
S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
[No Abstract] [Full Text] [Related]
20. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.
Waning B; Diedrichsen E; Moon S
J Int AIDS Soc; 2010 Sep; 13():35. PubMed ID: 20840741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
